Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01759342 · ClinicalTrials.gov registry record · NA
Comprehensive Exercise Training Program During Hospitalization for an Acute CF Exacerbation
A NA study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 23
- Enrollment target
NCT01759342: Completed NA study, sponsored by University of Alabama at Birmingham.
NCT01759342 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 23 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01759342, a NA study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
Study Summary
This protocol was designed to assess if when subjects with CF are admitted to the hospital for a pulmonary exacerbation if a comprehensive exercise program (moderate to high intensity aerobic, resistance, flexibility and balance exercises) was superior to our "usual care intervention (30 min/day of self selected mode and intensity of exercise) in improving aerobic capacity, muscle strength/power, flexibility and balance.
Interventions
- BEHAVIORAL Aerobic exercise
- BEHAVIORAL Balance exercise
- BEHAVIORAL Resistance exercise
- BEHAVIORAL Flexibility and postural exercise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2008-04 |
| Est. Completion | 2008-10 |
| Phase | NA |
What the finished NCT01759342 record still lists
NCT01759342 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 4 interventions - of which Aerobic exercise is the first listed.
NCT01759342 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01759342 about?
NCT01759342 is a clinical study titled "Comprehensive Exercise Training Program During Hospitalization for an Acute CF Exacerbation". This protocol was designed to assess if when subjects with CF are admitted to the hospital for a pulmonary exacerbation if a comprehensive exercise program (moderate to high intensity aerobic, resistance, flexibility and balance exercises) was superior to our "usual care intervention (30 min/day of ...
What is the current status of trial NCT01759342?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2008-04. Estimated completion is 2008-10.
What interventions are being tested in trial NCT01759342?
The interventions under investigation include: Aerobic exercise (BEHAVIORAL), Balance exercise (BEHAVIORAL), Resistance exercise (BEHAVIORAL), Flexibility and postural exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT01759342?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01759342's enrollment target sits among peer trials
23 1755th of 2000 higher than 245 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia